Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

TRETINOIN CRS (50 MG)

TRETINOIN CRS (50 MG)

302-79-4

DISCOVER
TRIAMCINOLONE CRS (100 MG)

TRIAMCINOLONE CRS (100 MG)

124-94-7

DISCOVER
TRIAMCINOLONE ACETONIDE CRS (150 MG)

TRIAMCINOLONE ACETONIDE CRS (150 MG)

76-25-5

DISCOVER
TRIAMCINOLONE HEXACETONIDE CRS (100 MG)

TRIAMCINOLONE HEXACETONIDE CRS (100 MG)

5611-51-8

DISCOVER
TRIAZOLAM CRS - * PSY (10 MG)

TRIAZOLAM CRS - * PSY (10 MG)

28911-01-5

DISCOVER
TRICAPRIN CRS (310 MG)

TRICAPRIN CRS (310 MG)

621-71-6

DISCOVER
TRICAPROIN CRS (40 MG)

TRICAPROIN CRS (40 MG)

621-70-5

DISCOVER
TRICAPRYLIN CRS (450 MG)

TRICAPRYLIN CRS (450 MG)

538-23-8

DISCOVER
TRICHLOROTRIFLUOROETHANE CRS - * ODS (2.5 ML)

TRICHLOROTRIFLUOROETHANE CRS - * ODS (2.5 ML)

76-13-1

DISCOVER
TRIETHYL CITRATE - REFERENCE SPECTRUM (N/A)

TRIETHYL CITRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
TRIFLUOPERAZINE HYDROCHLORIDECRS (30 MG)

TRIFLUOPERAZINE HYDROCHLORIDECRS (30 MG)

440-17-5

DISCOVER
TRIFLUSAL CRS (50 MG)

TRIFLUSAL CRS (50 MG)

322-79-2

DISCOVER